Biotechnology News

April 24, 2012

BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics announces addition of Dr. Arthur A. Levin to its Executive Team as EVP of R&D. Dr. Levin to help advance microRNA (miRNA)-based therapeutics pipeline into clinical development.

April 24, 2012

BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics Secures $20 M Series B Financing. Funding to advance company's pipeline of compelling microRNA (miRNA)-based therapeutic candidates.

April 24, 2012

WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) announced that detailed positive data from CONFIRM, the second Phase 3 clinical trial of oral BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS...

April 24, 2012

DUBLIN--(BUSINESS WIRE)--ICON (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter...

April 24, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics AB (Publ) (STO:PREC), Corporate Identity No. 556545-6596 Interim Report for the Period January – March 2012 The group’s net sales for the first quarter was SEK 4.7 million (3.6) The...

April 24, 2012

ST. LOUIS--(BUSINESS WIRE)--Partek Incorporated is debuting new enhancements and features to their next generation sequencing software, Partek® Flow®, at the Bio-IT World Expo and Conference in Boston, April 24-26.

April 24, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen reported the initial validation of two additional therapeutic product candidates, CGEN-15031 and CGEN-15051, in animal models of autoimmune diseases.

April 24, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Torax Medical today announced Keck Medical Center of USC, Mayo Clinic Florida, and UC San Diego Health System of UCSD are among the first centers offering a new procedure using the LINX® Reflux Management System...

April 24, 2012

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--MicroDose Therapeutx, Inc. announced today that it has concluded the second of two Phase I studies with its novel inhaled antiviral fusion inhibitor, MDT-637, for the treatment of RSV infection.

April 24, 2012

PALO ALTO, Calif. & OSAKA, Japan--(BUSINESS WIRE)--Affymax, Inc. (NASDAQ:AFFY) and Takeda Pharmaceutical Company Limited (TSE:4502), today announced that OMONTYS® (peginesatide) Injection is now available only for use in treating anemia due...

April 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter...

April 24, 2012

WASHINGTON & PORTOLA VALLEY, Calif.--(BUSINESS WIRE)--Greenleaf Health LLC today announced that Linda Carter and Alice Jack – both experts within the field of FDA regulated medical products – have joined the firm.

April 24, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex to Present at the Deutsche Bank 37th Annual Health Care Conference

April 24, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results for the three months ended March 31, 2012. The Company reported net product sales of Soliris® (eculizumab) of $244.7 million, an...

April 24, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica will be presenting at the JMP Securities Research Conference on May 14, 2012 in San Francisco. Mark Weinstein will update investors on the company's progress, and it will be webcast.

April 24, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals updates shareholders on its clinical and corporate progress for 2011 and early 2012, advancing its goal of regulatory approval for its novel oncological & derma therapies.

April 24, 2012

KANSAS CITY, Mo.--(BUSINESS WIRE)--Diatron Group (Diatron), a Swiss-based provider of hematology and clinical chemistry analyzers, has received FDA 510(k) premarket approval for its advanced laser optics hematology analyzer.

April 24, 2012

REDWOOD CITY, Calif. & DANVILLE, Va.--(BUSINESS WIRE)--Virdia today announced the opening of its demonstration facility at its new technology center in Danville, VA.

April 24, 2012

OXFORD, England--(BUSINESS WIRE)--PsiOxus Therapeutics has opened a new state of the art laboratory at Milton Park as part of its expansion plans. The facility has been designed and equipped as a category two laboratory for the handling of live...

April 24, 2012

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ: 4573) pleased to announce the completion of a phase I clinical study of RK-023, a new compound that is being developed for the treatment of hypotrichosis of the eyelashes.

April 24, 2012

GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment provider, started off fiscal 2012 with substantial gains in order intake, sales revenue and earnings. Based on the company'...

April 24, 2012

DUBAI--(BUSINESS WIRE)--World Heart Federation, World Congress of Cardiology Scientific Sessions 2012 - April 23, 2012 Seventy patient and professional organisations from 39 countries united in Dubai this week at the World Heart Federation’s...

April 24, 2012

BROOMFIELD, Colo.--(BUSINESS WIRE)--OEL Fastrac, a simple an affordable way to obtain occupational exposure limits for active pharmaceutical ingredients. Visit affygility.com for more information.

April 23, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) will webcast its annual meeting of shareholders on Tuesday, May 8, 2012, at 9:00 a.m. Central Time. This call is being webcast by Thomson Reuters and can be accessed along...

April 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the first quarter of 2012. First quarter 2012 results: Revenue of $273 million, a 3% decrease compared to $283 million in the first quarter of 2011...

April 23, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (Nasdaq:ARRY) will report financial results for the third quarter of fiscal 2012 on Monday, April 30, 2012, and will hold a conference call on Tuesday, May 1, 2012 at 9:00 a.m. Eastern time to...

April 23, 2012

GOLDEN, Colo.--(BUSINESS WIRE)--Luca Technologies Inc., a global market leader in biogenic methane gas creation and production, today announced that it has decided not to pursue its initial public offering due to adverse market conditions. The...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that David Warshawsky, Ph.D., CEO of BioTime’s subsidiary LifeMap Sciences, Inc. will provide and update on product development at an investor meeting in New York...

April 23, 2012

NEW YORK--(BUSINESS WIRE)--Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of Ardea Biosciences, Inc. (“Ardea” or the “Company”) (NASDAQ:RDEA) (ISIN: US03969P1075) concerning the proposed acquisition of...

April 23, 2012

DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (Amex: AXK) announced today that an investment group formed by Jack Schuler, John Patience, and Larry Mehren will invest a total of up to $35 million in Accelr8’s common stock. The purpose...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that BioTime’s CEO Michael West, Ph.D. will provide and update the development of OTX-CP07 by BioTime’s subsidiary OrthoCyte Corporation at an investor meeting in...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that Steven Kessler, Ph.D., Vice President of Research at BioTime’s subsidiary ReCyte Therapeutics, Inc. will provide and update on the development of reprogramming...

April 23, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. will host its first-quarter 2012 financial results conference call and webcast on Tuesday, May 1, at 10 a.m. ET.

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that Joseph Wagner, Ph.D., the CEO of BioTime’s subsidiary OncoCyte Corporation and Karen B. Chapman, Ph.D., Director of Bioinformatics will provide updates on the...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that Charles S. Irving, Ph.D., the CEO of BioTime’s subsidiary Cell Cure Neurosciences, Ltd. will provide an update on the development of OpRegen® at an investor...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex:BTX) announced today that William Tew, Ph.D., BioTime’s Chief Commercial Officer will provide an update on the development of ReneviaTM (formerly known as HyStem®-Rx) at an investor...

April 23, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--Landec Corporation (Nasdaq:LNDC), a company that develops and markets patented products for food, agricultural and biomedical applications, announced today that its wholly owned food subsidiary, Apio, Inc.,...

April 23, 2012

HOUSTON--(BUSINESS WIRE)--Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, closed a $3 million Series A convertible preferred stock financing.

April 23, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck today announced the launch of YourPartnerInEpilepsy.com, a new destination for the epilepsy community to learn about epilepsy, get involved and find inspiration. Among the website’s many features include...

April 23, 2012

EXTON, Pa.--(BUSINESS WIRE)--After three months on the market, share of Regeneron’s Eylea has increased to 6 percent

April 23, 2012

ATLANTA--(BUSINESS WIRE)--Capsalus Corp. announced that the necessary revenue numbers for its fourth quarter are not yet available for its Fiscal 2011 10-K annual report for the fiscal year ending Dec. 31, 2011.

April 23, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The rapid growth of Phase IV clinical trials has meant expanded budgets for post-marketing studies and a subsequent need to manage complex outsourcing relationships.

April 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OmniGuide, Inc., a commercial stage medical device company, today announced that it has appointed Carl Vause as its Vice President of Marketing. Mr. Vause most recently served as the Global Franchise Leader for...

April 23, 2012

SIOUX FALLS, S.D.--(BUSINESS WIRE)--The South Dakota Biotechnology Association is expanding its annual poster session for researchers by incorporating the event into its annual summit. The poster session will focus on the following areas of...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) and its wholly owned subsidiary OrthoCyte Corporation reported today a means of manufacturing cartilage from human embryonic stem cells that is suited for industrial scale-up of a...

April 23, 2012

MILAN--(BUSINESS WIRE)--Revenues of €191.7 million, a 2.8%increase (5.1% as reported) over Q1 2011; Adjusted net profit up 10.3% to €11.2 million, 5.8% of revenues (5.6% in Q1 2011)

April 23, 2012

CAMBRIDGE, Mass. & WEST CHICAGO, Ill.--(BUSINESS WIRE)--Metabolix, Ball Horticultural Company and FPG, announced that the Mirel based biodegradable SoilWrap plant containers are now available at Home Depot and Shopko stores in Midwest and...

April 23, 2012

ABBOTT PARK, Ill. & ST. PAUL, Minn.--(BUSINESS WIRE)--Abbott (NYSE: ABT) and St. Jude Medical (NYSE: STJ) today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of...

April 23, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, a leading global medical device manufacturer, today announced that its ViaValve™ Safety I.V. Catheter has been cleared by the U.S. Food and Drug Administration (FDA) and can be marketed in the...